Hyperkalemia after acute metabolic decompensation in two children with vitamin B12-unresponsive methylmalonic acidemia and normal renal function.
The patients affected by vitamin B12-unresponsive methylmalonic acidemia (MMA) on the long run develop chronic renal disease with interstitial nephropathy and progressive renal insufficiency. The mechanism of nephrotoxicity in vitamin B12-unresponsive MMA is not yet known. Chronic hyporeninemic hypoaldosteronism has been found in many cases of methylmalonic acidemia, hyperkalemia and renal tubular acidosis type 4. We report 2 patients affected by B12-unresponsive methylmalonic acidemia diagnosed at the age of 23 months and 5 years, respectively, with normal glomerular filtration and function. They showed hyporeninemic hypoaldosteronism and significant hyperkalemia requiring sodium potassium exchange resin (Kayexalate) therapy after an episode of metabolic decompensation leading to diagnosis of MMA. In both children, hyporeninemic hypoaldosteronism and hyperkalemia disappeared after 6 months of good metabolic control.
Pela
I
I
Department of Pediatrics, University of Florence, Via Luca Giordano 13, 50132 Firenze, Italy. vana.pela@unifi.it
Gasperini
S
S
Pasquini
E
E
Donati
M A
MA
D002675:Child, Preschool; D005260:Female; D005650:Fumarates / Q000097:blood*; D006801:Humans; D006947:Hyperkalemia / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy; D006994:Hypoaldosteronism / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D007223:Infant; D007668:Kidney / Q000503:physiopathology; D008297:Male; D008298:Maleates / Q000097:blood*; D008661:Metabolism, Inborn Errors / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology / Q000628:therapy; D014805:Vitamin B 12 / Q000627:therapeutic use
D005650:Fumarates; D008298:Maleates; C073341:citraconic acid; D014805:Vitamin B 12